Valiant Laboratories

Valiant Laboratories EBIT Margin

The EBIT Margin (Operating Margin) of Valiant Laboratories (VALIANTLAB.NS) as of Nov 4, 2026 is 1.12 %. In the previous year, EBIT Margin (Operating Margin) was 12.84 % — a change of -91.24% (lower).

EBIT Margin

1.12 %

YoY

-91.24%

Last updated:

EBIT Margin (Operating Margin) of Valiant Laboratories is 2026 1.12 % . EBIT Margin (Operating Margin) of Valiant Laboratories was 2025 12.84 % . It decreases by -91.24% lower compared to the previous year.

For Valiant Laboratories, the operating (EBIT) margin of 1.1% is down versus 13.7% a few years ago.

The Valiant Laboratories EBIT Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBIT Margin
Date
EBIT Margin
Jan 1, 2021
25.99 INR
Jan 1, 2022
13.72 INR
Jan 1, 2023
10.28 INR
Jan 1, 2024
3.99 INR
Jan 1, 2025
12.84 INR
Jan 1, 2026
1.12 INR
The Valiant Laboratories EBIT Margin history
YEAREBIT MarginYoY
1.12 %-91.24%
12.84 %+221.94%
3.99 %-61.18%
10.28 %-25.12%
13.72 %-47.20%
25.99 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valiant Laboratories Stock analysis

What does Valiant Laboratories do? Valiant Laboratories Ltd manufactures paracetamol API/bulk drug for pharmaceutical applications, targeting medical conditions such as headache, muscle ache, arthritis, back ache, toothache, cold, and fever. The company operates a single manufacturing facility at Tarapur industrial estate, approximately 150 km from Nhava Sheva Port (JNPT), producing specialty chemicals and pharma intermediates for domestic and international markets. Its subsidiary, VALIANT ADVANCED SCIENCES PRIVATE LIMITED, supports the company's operations in the pharmaceutical sector. The firm's primary revenue comes from selling paracetamol API and specialty chemicals to pharmaceutical companies and distributors globally. Manufacturing focuses on high-demand applications like pain relief and fever treatment, with products distributed across India and abroad. The company leverages its Tarapur facility's proximity to Nhava Sheva Port for efficient export logistics. Valiant Laboratories Ltd serves the pharmaceutical industry by supplying essential active ingredients, particularly paracetamol, which is widely used in over-the-counter medications. The company's manufacturing capabilities for specialty chemicals and pharma intermediates cater to both domestic and international clients seeking reliable API sources. Its single-location production model ensures focused resource allocation for consistent output quality. Valiant Laboratories is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Valiant Laboratories stock

EBIT Margin (Operating Margin) of Valiant Laboratories is 1.12 % in 2026.

EBIT Margin (Operating Margin) of Valiant Laboratories changed from 12.84 % to 1.12 %, representing a -91.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBIT Margin (Operating Margin) Valiant Laboratories since 2006 – with annual values, charts, and detailed analysis.

EBIT Margin measures operating profitability as a percentage of revenue. It shows how much profit a company makes from operations before interest and taxes.

A 'good' varies by industry and company stage. On Eulerpool, you can compare EBIT Margin (Operating Margin)'s Valiant Laboratories with sector peers and the industry average to assess whether it is attractive.

To evaluate EBIT Margin (Operating Margin)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EBIT Margin (Operating Margin).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Valiant Laboratories

All Key Metrics — Valiant Laboratories